Neuromod Secures €10 Million to Advance Tinnitus Treatment with Lenire!
Tinnitus sufferers may soon benefit from further advancements in treatment, as Neuromod has successfully closed a €10 million financing round to accelerate the commercial rollout of its Lenire device. As reported by Med-Tech Insights, this investment will support the expansion of Lenire, a non-invasive neuromodulation treatment for tinnitus that has already received regulatory approval in key markets.
With millions affected by tinnitus worldwide, this funding signals a growing commitment to tackling unmet medical needs through innovative technology. Neuromod’s success reflects the increasing investor confidence in MedTech solutions designed to improve patient outcomes.
🔗 Read the full article on Med-Tech Insights: Neuromod Closes €10 Million Financing Round for Lenire Device
Credit for images and content: MedTech Insights + Neuromod
____________________________________________________________________________________________________________________________________________________________________________________________________
Cure Talent is a recruitment agency dedicated to the medical technology industry. Whether you are looking for a new role in the medical device sector or you’re an innovative medical device, digital health, or biotech company looking for staff, get in touch with the team today and explore how Cure Talent can help!